NY-CELONIS
Celonis , the global leader in execution management, announced the acquisition of Process Analytics Factory GmbH (PAF), a leading provider of process mining insights for Microsoft Power BI. This acquisition will enable millions of Microsoft Power Platform users to utilize Celonis’ market leading Execution Management System (EMS) for process mining, automation, and collaboration.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220329005245/en/
The acquisition of PAF is part of Celonis’ strategy to enable companies everywhere and in all industries to use process mining within the Celonis EMS to reveal and fix process inefficiencies. Celonis is committed to empowering users of the top automation, collaboration, and workflow platforms to run their businesses using Celonis’ unique process insights and intelligent, targeted actions.
The PAFnow process mining product is completely integrated into Microsoft Power BI and Microsoft Office 365 for the analysis, visualization and optimization of almost any process. 97 percent of the Fortune 500, and over 260,000 companies globally, use Microsoft Power BI.
The Celonis EMS combines, in one integrated cloud platform, real-time data, process intelligence, and targeted action to impact top, bottom, and greenline business performance at speed. Customers looking to get full clarity on how their business processes are running - whether across supply chains, shared service centers, or system landscapes - can now benefit from the unique and advanced capabilities of the Celonis EMS within their familiar Microsoft environments.
Maximilian Gerbert, project lead at Mercedes-Benz Management Consulting, said: “We - the Digital Accelerator of Mercedes-Benz - are a data-driven department with a business intelligence strategy built over years, but once we brought process mining into our BI infrastructure we were able to see the full picture and identify process inefficiencies throughout our company that we never could before. When supply chain issues come up, we use insights from process mining within BI to pinpoint the bottlenecks and take action to fix them — before they impact our cash flow and our customer experience. We are excited by the news of the Celonis acquisition and the ability to leverage the powerful capabilities of the Celonis EMS within our Microsoft environment.”
"It’s great to see Celonis and PAF join forces,” said Linus Linder, Head of IT at Muller - Die lila Logistik Service GmbH. “Now we can benefit from the real-time data, process intelligence, and targeted action in the Celonis EMS within our familiar Microsoft Power BI environment."
The rapid adoption of the Celonis EMS comes on the heels of a generational shift to use process insights and intelligence to change how businesses are run.
According to Gartner® the market for hyper-automation software will reach nearly $860 billion by 20251 . But many businesses do not maximize the value of their digital investments because they lack insight into outdated processes holding back business operations. According to a Forrester report commissioned by Celonis, process mining has hit an inflection point in 2022 as decision makers demand better execution by finding and fixing process inefficiencies.
“Since we started 11 years ago, the Celonis mission has always been the same - to help our customers reach the full potential of their business performance by removing process inefficiencies - and that requires Celonis to be everywhere,” said Alex Rinke, co-CEO and co-founder of Celonis. “The PAF acquisition enables the millions of users of the Microsoft Power Platform to use Celonis’ unique data and intelligent insights to power analytics, automation, and collaboration.”
“This combination leverages the strength of Celonis market leadership with the foundation that PAF has created in the Microsoft Power Platform. This allows our companies to build the bridge between the Microsoft Power Platform and the Celonis Execution Management System,” said Tobias Rother, CEO and founder of PAF. “We are thrilled to help put Celonis into the hands of such a large and fast-growing community of business leaders.”
“In our inaugural HFS SaaS XXV 2022 report we ranked Celonis as the top private SaaS company in Overall Rank, Business Value Creation, Partner Engagement, and OneOffice Alignment,” said Phil Fersht, CEO and Chief Analyst of HFS Research. “The acquisition of PAF demonstrates why Celonis is ranked alongside Microsoft, Salesforce, Amazon, Adobe, and Google for shaping the future of native automation, data, and process design. Celonis is strategically moving its unique process data and intelligent insights into the world’s largest work, automation, and analytics platforms.”
"The purpose of process mining is to gain a fact-based understanding of business process variance and inefficiency to systematically improve processes to maximize performance while aligning with the overall goals of a business. Embedding process mining into common analytics platforms makes it easier for teams to work together using familiar tools,” said Maureen Fleming, Program Vice President for the IDC Intelligent Process Automation Market Research and Advisory Service.
The PAFnow software capabilities will debut in Celonis Experiences at Celonis World Tour 2022 . Celonis Experiences will showcase how customers can seamlessly integrate Celonis EMS with Microsoft Power BI reporting, collaborate with Microsoft Teams, and trigger flows in Microsoft Power Automate.
About Celonis
Celonis helps organizations to execute on their data. Powered by its market-leading process mining core, the Celonis Execution Management System provides a set of applications, a developer studio and platform capabilities for business executives and users to eliminate billions in corporate inefficiencies, provide better customer experience and reduce carbon emissions. Celonis has thousands of implementations in global customers and is headquartered in Munich, Germany and New York City, USA with 20 offices worldwide.
© 2022 Celonis SE. All rights reserved. Celonis, Execution Management System, EMS and the Celonis “droplet” logo are trademarks or registered trademarks of Celonis SE in Germany and other jurisdictions. All other product and company names are trademarks or registered trademarks of their respective owners.
1 Gartner, Forecast Analysis: Hyperautomation of Enablement Software, Worldwide, Cathy Tornbohm, Fabrizio Biscotti, Rachel Chippendale, March 22, 2021.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220329005245/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Stafford Establishes Timberland Continuation Fund at USD 1.2 billion4.12.2025 10:53:00 CET | Press release
This marks Stafford’s second timberland fund at over USD 1 Billion in 2025, backed by strong existing investor support and new capital commitments from global institutional investors Stafford Capital Partners (“Stafford”) today announced it has established a USD 1.2 billion continuation vehicle, the Stafford International Timberland Continuation Fund (The Continuation Fund or The Fund), marking a significant milestone in the firm’s strategic management of its timberland holdings. The Continuation Fund is a "roll-up" of three of Stafford’s existing core timberland funds – Stafford International Timberland funds VI, VII and VIII – into a new perpetual fund that will hold 74 high-quality core timberland assets. The fully-deployed portfolio took Stafford seven years to construct and holds interests in over 6.3m acres of commercial timberland in the USA, New Zealand, Australia and Latin America. This includes a number of assets that are seen as key strategic holdings in these regions where
Smartstream Introduces Agentic AI ‘Smart Agents’ for Investigations and Exceptions Handling4.12.2025 09:55:00 CET | Press release
Smartstream, the trusted data solutions provider for leading global financial institutions and enterprises, today announces the preview of Smart Agents for Investigations, a breakthrough in financial operations that brings augmented and autonomous exception handling to reconciliations and back-office processes. The new investigation agent combines domain-trained AI agents, workflow adoption, and embedded controls to triage, investigate, resolve, and learn from exceptions - reducing manual effort, accelerating time to resolution, and strengthening auditability. It will add a layer of intelligence on top of Smartstream’s current reconciliations and exceptions solutions. It understands the breaks context, adheres to customer playbooks and reaches out for missing information. It documents every step for audit and compliance, allowing analysts to focus on risk. Finally, it augments the analyst’s investigation with contextual information radically changing the user experience to review and a
LabGenius Therapeutics Announces New Collaboration with Sanofi for Multiple AI/ML-driven Antibody Optimisation Programmes4.12.2025 09:00:00 CET | Press release
The companies have entered into a new collaboration where LabGenius Therapeutics will apply its ML-driven antibody discovery platform (EVA™) to optimise potential therapeutic NANOBODY® proteins for multiple new targets LabGenius Therapeutics (“LabGenius”), a drug discovery company combining machine learning (ML) and high-throughput experimentation to optimise potential therapeutic antibodies, today announced a second collaboration with Sanofi. This collaboration combines LabGenius’ AI/ML-driven antibody design capabilities with Sanofi’s expertise in the development of therapeutic NANOBODY® molecules to co-optimise proteins for therapeutically valuable properties. Following the success of their first collaboration, LabGenius will apply the EVA™ platform to optimise NANOBODY® molecules for multiple new targets in the area of inflammation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251204759388/en/ “We are truly excited abo
GoWit One: The Unified AI Operating System Set to Revolutionize Commerce & Retail Media4.12.2025 07:09:00 CET | Press release
WPP Turkey has been selected as a pilot partner to deploy GoWit One, cutting campaign setup time to 10 minutes. GoWit, a global AdTech leader in omnichannel Commerce and Retail Media, announced the launch of GoWit One, the unified AI operating system that brings automation, unification, and real-time intelligence into a single ad platform for agencies operating across multiple retailers, channels, and markets. By bringing these three elements into one dashboard, GoWit One addresses the industry's most critical bottleneck: operational inefficiency. The platform enables agencies to manage campaigns across multiple retailers, channels, and markets, reducing manual AdOps workflows by 98%, turning a process that used to take hours into as little as 10 minutes. Solving the “Fragmentation Crisis” Despite the explosive growth of Retail Media, the industry faces a significant hurdle. According to the IAB, 70% of the market still lacks end-to-end AI adoption. Media buyers are currently forced to
Galderma Secures ‘BBB’ Credit Rating With Positive Outlook from S&P Global Ratings4.12.2025 07:00:00 CET | Press release
‘BBB’ long-term issuer credit rating from S&P Global RatingsPositive outlook, reflecting expected profitability improvement, ramp up of Nemluvio, and continued deleveraging and balance sheet improvementRecognition of Galderma’s science-based dermatology portfolio and global operations Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced that S&P Global Ratings (S&P) has assigned the company a ‘BBB’ long-term issuer credit rating with a positive outlook. The rating reflects Galderma’s strong track record of growth and its leading positions across Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. S&P notes the company’s well-established brand portfolio, global footprint, including an expanding presence in emerging markets, and continued investment in science-based innovation. S&P highlights momentum from recent launches, including Nemluvio® (nemolizumab), alongside improving profitability and expanding free operating cash flow
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom